12-8604885-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_020661.4(AICDA):c.465C>A(p.His155Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,610,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. H155H) has been classified as Benign.
Frequency
Consequence
NM_020661.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AICDA | NM_020661.4 | c.465C>A | p.His155Gln | missense_variant | 4/5 | ENST00000229335.11 | NP_065712.1 | |
AICDA | NM_001330343.2 | c.435C>A | p.His145Gln | missense_variant | 4/5 | NP_001317272.1 | ||
AICDA | NM_001410970.1 | c.427+330C>A | intron_variant | NP_001397899.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AICDA | ENST00000229335.11 | c.465C>A | p.His155Gln | missense_variant | 4/5 | 1 | NM_020661.4 | ENSP00000229335.6 |
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149230Hom.: 0 Cov.: 26
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461038Hom.: 0 Cov.: 66 AF XY: 0.00 AC XY: 0AN XY: 726810
GnomAD4 genome AF: 0.00000670 AC: 1AN: 149230Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 72536
ClinVar
Submissions by phenotype
Hyper-IgM syndrome type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2023 | This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 155 of the AICDA protein (p.His155Gln). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AICDA-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at